217 related articles for article (PubMed ID: 9374381)
21. Effect of radiation and tirapazamine (SR-4233) on three melanoma cell lines.
Zhang M; Stevens G
Melanoma Res; 1998 Dec; 8(6):510-5. PubMed ID: 9918413
[TBL] [Abstract][Full Text] [Related]
22. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay.
Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Takahashi M; Abe M
Br J Cancer Suppl; 1996 Jul; 27():S61-4. PubMed ID: 8763848
[TBL] [Abstract][Full Text] [Related]
23. The effect of low pH and hypoxia on the cytotoxic effects of SR4233 and mitomycin C in vitro.
Skarsgard LD; Vinczan A; Skwarchuk MW; Chaplin DJ
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):363-7. PubMed ID: 8195034
[TBL] [Abstract][Full Text] [Related]
24. The 2-nitroimidazole EF5 is a biomarker for oxidoreductases that activate the bioreductive prodrug CEN-209 under hypoxia.
Wang J; Foehrenbacher A; Su J; Patel R; Hay MP; Hicks KO; Wilson WR
Clin Cancer Res; 2012 Mar; 18(6):1684-95. PubMed ID: 22167409
[TBL] [Abstract][Full Text] [Related]
25. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
26. Exploiting the Inherent Photophysical Properties of the Major Tirapazamine Metabolite in the Development of Profluorescent Substrates for Enzymes That Catalyze the Bioreductive Activation of Hypoxia-Selective Anticancer Prodrugs.
Shen X; Laber CH; Sarkar U; Galazzi F; Johnson KM; Mahieu NG; Hillebrand R; Fuchs-Knotts T; Barnes CL; Baker GA; Gates KS
J Org Chem; 2018 Mar; 83(6):3126-3131. PubMed ID: 29461834
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of the bioreductive cytotoxin SR 4233 by tumour cells: enzymatic studies.
Wang J; Biedermann KA; Wolf CR; Brown JM
Br J Cancer; 1993 Feb; 67(2):321-5. PubMed ID: 8431360
[TBL] [Abstract][Full Text] [Related]
28. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of tirapazamine by multiple reductases in the nucleus.
Delahoussaye YM; Evans JW; Brown JM
Biochem Pharmacol; 2001 Nov; 62(9):1201-9. PubMed ID: 11705453
[TBL] [Abstract][Full Text] [Related]
30. Reaction of the hypoxia-selective antitumor agent tirapazamine with a C1'-radical in single-stranded and double-stranded DNA: the drug and its metabolites can serve as surrogates for molecular oxygen in radical-mediated DNA damage reactions.
Hwang JT; Greenberg MM; Fuchs T; Gates KS
Biochemistry; 1999 Oct; 38(43):14248-55. PubMed ID: 10571998
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of tirapazamine (SR 4233, Win 59075)-induced hepatocyte toxicity under low oxygen concentrations.
Khan S; O'Brien PJ
Br J Cancer; 1995 Apr; 71(4):780-5. PubMed ID: 7710944
[TBL] [Abstract][Full Text] [Related]
32. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.
Plumb JA; Gerritsen M; Workman P
Br J Cancer; 1994 Dec; 70(6):1136-43. PubMed ID: 7526885
[TBL] [Abstract][Full Text] [Related]
33. Bioreductive metabolism of SR-4233 (WIN 59075) by whole cell suspensions under aerobic and hypoxic conditions: role of the pentose cycle and implications for the mechanism of cytotoxicity observed in air.
Tuttle SW; Hazard L; Koch CJ; Mitchell JB; Coleman CN; Biaglow JE
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):357-62. PubMed ID: 8195033
[TBL] [Abstract][Full Text] [Related]
34. Effects of cytokine-induced macrophages on the response of tumor cells to banoxantrone (AQ4N).
Mehibel M; Singh S; Chinje EC; Cowen RL; Stratford IJ
Mol Cancer Ther; 2009 May; 8(5):1261-9. PubMed ID: 19435866
[TBL] [Abstract][Full Text] [Related]
35. Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.
Siim BG; van Zijl PL; Brown JM
Br J Cancer; 1996 Apr; 73(8):952-60. PubMed ID: 8611431
[TBL] [Abstract][Full Text] [Related]
36. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors.
Rampling R; Cruickshank G; Lewis AD; Fitzsimmons SA; Workman P
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):427-31. PubMed ID: 8005794
[TBL] [Abstract][Full Text] [Related]
37. The effect of pH on the aerobic and hypoxic cytotoxicity of SR4233 in HT-29 cells.
Skarsgard LD; Skwarchuk MW; Vinczan A; Chaplin DJ
Br J Cancer; 1993 Oct; 68(4):681-3. PubMed ID: 8398693
[TBL] [Abstract][Full Text] [Related]
38. 3-amino-1,2,4-benzotriazine 4-oxide: characterization of a new metabolite arising from bioreductive processing of the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).
Fuchs T; Chowdhury G; Barnes CL; Gates KS
J Org Chem; 2001 Jan; 66(1):107-14. PubMed ID: 11429885
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation.
Kim JY; West CM; Valentine H; Ward TH; Patterson AV; Stratford IJ; Roberts SA; Hendry JH
Radiother Oncol; 2004 Mar; 70(3):311-7. PubMed ID: 15064018
[TBL] [Abstract][Full Text] [Related]
40. Studies with bifunctional bioreductive drugs. II. Cytotoxicity assayed with A-549 lung carcinoma cells of human origin.
Roizin-Towle L; Pirro JP; Hall EJ
Radiat Res; 1990 Oct; 124(1 Suppl):S50-5. PubMed ID: 2236511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
